• Home
• spike meaning
• New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

4.9 (781) · $ 4.50 · In stock

COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies

Structural biology of SARS-CoV-2 and implications for therapeutic development

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

Immune Network

COVID-eVax, An Electroporated DNA Vaccine Candidate, 55% OFF

SARS-CoV-2 and its impact on the cardiovascular and digestive

Antibody that inhibits broad range of sarbecoviruses found - UW Medicine

Browse Articles Cellular & Molecular Immunology

COVID-eVax, An Electroporated DNA Vaccine Candidate, 55% OFF

An outlook on potential protein targets of COVID-19 as a druggable site

Researchers develop a nasal vaccine that prevents COVID-19 in preclinical studies

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

Junzhi Wang's research works National Institutes for Food and Drug Control, China, Beijing (NIFDC) and other places